All filings

AGS Health Limited

UDRHP · filed 14 Aug 2026

Draft filed

This is a draft. SEBI has not cleared it, there is no final price yet, and it may never become an IPO.

AGS Health Limited is a healthcare company that has recently completed an acquisition, resulting in a consolidated business with operations both within and outside of India. The IPO structure consists of a fresh issue of Rs 18,000 crore and an offer for sale of Rs 30,000 crore, with the offer for sale comprising 62.5% of the total issue size. The company reported a revenue of Rs 2,041.42 crore and a profit after tax of Rs 206.95 crore in the latest period, with revenue growing at a CAGR of 43.67%. The most material risks include the unreliability of the unaudited proforma financial information for future projections and the challenges of managing an internationally dispersed business under a single point of control.

What stands out

Large related-party dealings. Related-party transactions are 176.2% of revenue.

Risk factor. The Unaudited Proforma Financial Information included in the Updated Draft Red Herring Prospectus-I is not indicative of our future financial condition, results of operations or cash flows.

Strong revenue growth. Restated revenue CAGR of 43.7%.

How the offer is structured

Fresh issue

₹18.00k Cr

New capital into the company

Offer for sale

₹30.00k Cr

Goes to selling shareholders

OFS share

63%

Debt repayment

₹16.00k Cr

From fresh proceeds

  • Repayment and/or prepayment, in part or full, of certain borrowings availed by two wholly owned indirect Subsidiaries of our Company, namely, AGS Health BCP LLC and AGS Health BCP Holdings, Inc., through investment in such Subsidiaries₹16.00k Cr
  • General corporate purposes

Restated financials

Revenue

₹2.04k Cr

Latest fiscal year

Profit after tax

₹207 Cr

Revenue CAGR

43.7%

Return on equity

4.3%

Debt / equity

0.87

PAT CAGR

33.8%

Fiscal yearRevenueEBITDAPATNet worth
2024₹989 Cr₹116 Cr₹512 Cr
2025₹1.19k Cr₹143 Cr₹654 Cr
2026₹2.04k Cr₹207 Cr₹4.87k Cr

Promoters, litigation & related parties

Related-party

176.2%

Share of revenue

Except as disclosed in this section

Risks the company discloses

  • The Unaudited Proforma Financial Information included in the Updated Draft Red Herring Prospectus-I is not indicative of our future financial condition, results of operations or cash flows.(Financial Reporting)

  • The Unaudited Proforma Financial Information has not been prepared in accordance with accounting or other standards and practices generally accepted in jurisdictions other than India, such as Regulation S-X under the U.S. Securities Act.(Financial Reporting)

  • The Unaudited Proforma Financial Information is prepared for illustrative purposes only and is subject to change.(Financial Reporting)

  • The Unaudited Proforma Financial Information may not be an accurate representation of what our actual results of operations, cash flows and financial position would have been for such periods.(Financial Reporting)

  • The Unaudited Proforma Financial Information should not be relied upon as if it had been prepared in accordance with those standards and practices or generally accepted accounting principles.(Financial Reporting)

  • Consequent to the completion of the Acquisition, our Company is responsible for overseeing and managing our consolidated business operations within and outside of India.(Operational)

  • We may face difficulties managing and administering an internationally dispersed business and may not be able to achieve operational efficiencies.(Operational)

  • We may face challenges in managing the integrated yet dispersed business under a single point of control, such as in maintaining standards, controls or procedures.(Operational)

How this document reads, dimension by dimension

growthrevenue CAGR 43.7%
governanceRPT 176% of revenue
balance sheetdebt/equity 0.87x
profitabilityROE 4.2%
issue structure62% of the offer is OFS

Each bar is a fixed formula applied to the figures shown above, scored 0–100. This is a reading of what the company disclosed — not a recommendation to apply or avoid, not a price target, and not a prediction of listing performance. Dimensions that could not be extracted are excluded rather than assumed, so coverage varies between documents.

Figures are extracted automatically from the document filed with SEBI and may contain errors — the linked SEBI document is the authoritative record; analysed 24 Aug 2026.

Not investment advice

These lists are rules-based research, not buy recommendations. Rankings are generated from NSE & BSE data by a deterministic formula and do not account for your personal circumstances. For informational purposes only. Consult a SEBI-registered advisor before investing.

AGS Health Limited DRHP — SEBI filing analysis | DocStoX